CN Patent

CN107216319B — 一种2，4-二氨基嘧啶类衍生物、其制备方法及用途

Assigned to Shanghai Institute of Materia Medica of CAS · Expires 2021-10-08 · 5y expired

What this patent protects

本发明公开了一种2,4‑二氨基嘧啶类衍生物，及其药学上可接受的盐或药学上可接受的溶剂合物。同时还公开了其制备方法及用途。所述2,4‑二氨基嘧啶类衍生物，及其药学上可接受的盐或药学上可接受的溶剂合物可以作为酪氨酸激酶抑制剂。

USPTO Abstract

本发明公开了一种2,4‑二氨基嘧啶类衍生物，及其药学上可接受的盐或药学上可接受的溶剂合物。同时还公开了其制备方法及用途。所述2,4‑二氨基嘧啶类衍生物，及其药学上可接受的盐或药学上可接受的溶剂合物可以作为酪氨酸激酶抑制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN107216319B
Jurisdiction
CN
Classification
—
Expires
2021-10-08
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Institute of Materia Medica of CAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.